People power: Roach says AstraZeneca invests substantially to upskill and develop its people.
GLOBAL medical technology and pharmaceutical firms are turning to Malaysia as their investment destination, as they chart their mid-to-long term growth strategy across the region.
For biopharmaceutical company AstraZeneca, the focus going forward will be on achieving growth through a science-led innovation strategy, its country president and managing director Dr Sanjeev Panchal said.
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
